Friday, May 5, 2017

New Biomarker Signals Poor Response in Prostate Cancer

Medscape-20 hours ago
The finding, from a study published online May 3 in the Annals of Oncology, suggests that performing a blood test to quantify the AR gene could yield results that ...
Story image for Oncology from Markets Daily
Markets Daily

$10.87 Million in Sales Expected for Clovis Oncology Inc (CLVS ...

The Cerbat Gem-20 hours ago
Clovis Oncology logo Analysts expect that Clovis Oncology Inc (NASDAQ:CLVS) will report $10.87 million in sales for the current quarter, Zacks Investment ...
Story image for Oncology from USA Commerce Daily

If You Lack Direction On Clovis Oncology, Inc. (CLVS), You Need to ...

USA Commerce Daily-21 hours ago
With all other things going on, Clovis Oncology, Inc. (NASDAQ:CLVS) has been on a free fall — declining -18.23 percent in just three months. It looks like traders ...
Story image for Oncology from FactsReporter

Noteworthy Movers: Clovis Oncology, Inc. (CLVS), Gastar ...

FactsReporter-21 hours ago
The company announced its last quarter financial performance results on 02/22/2017. Clovis Oncology, Inc. (CLVS) belongs to Medical sector that declined ...
Story image for Oncology from Markets Daily
Markets Daily

Institutional Investors Have Increased Interest in Clovis Oncology ...

Midway Monitor-21 hours ago
Based on the latest SEC filings, institutions owning shares of Clovis Oncology, Inc. (NASDAQ:CLVS) have increased their transactions by 3.45%. Institutions now ...
Story image for Oncology from Pharmacy Practice News

The Top Killer In Breast Cancer May Surprise You

Pharmacy Practice News-21 hours ago
They are dying of heart disease,” said Dr. Cuellar, a clinical assistant professor and clinical oncology pharmacist at the University of Illinois Hospital and Health ...
Story image for Oncology from Post Analyst
Post Analyst

Zacks: Analysts Anticipate ZIOPHARM Oncology Inc. (ZIOP) to ...

Sports Perspectives-21 hours ago
ZIOPHARM Oncology logo Wall Street brokerages expect ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) to post earnings per share of ($0.12) for the current quarter ...
Story image for Oncology from Targeted Oncology

Tripathy Provides an Update on Neoadjuvant Treatment Strategies ...

Targeted Oncology-22 hours ago
In an interview with Targeted Oncology at the 2017 Miami Breast Cancer Conference (MBCC), Tripathy, a professor and chairman in the Department of Breast ...

Arizona Oncology Achieves Four-Year Accreditation for Radiation ...

Yahoo Finance-May 4, 2017
Arizona Oncology, one of the largest medical groups in Arizona and a practice in The US Oncology Network, has demonstrated compliance with the standards of ...

Stand Up To Cancer Releases Training Modules for Immuno ...

PR Newswire (press release)-May 4, 2017
"SU2C is at the forefront of immuno-oncology research, and nurses are an essential part of making these cutting-edge therapies effective and safe for patients," ...

No comments:

Post a Comment